Wockhardt gets approval to raise funds upto Rs 150 crore

22 Apr 2021 Evaluate

Wockhardt’s the Credit Facilities Committee of the Board of Directors, at its meeting held on April 21, 2021, has approved the raising of funds upto Rs 150 crore through issuance of Rated, Unlisted, Secured Non-Convertible Debentures on private placement basis, in one or more tranches/series to such eligible investors as maybe deemed appropriate.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Wockhardt Share Price

1360.10 28.75 (2.16%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×